485 
Tribes, and territories regarding the outcome of 
such requests; and 
(5) any differences in the processes developed 
under subsection (a) for geographically related emer-
gencies, such as weather events, and national emer-
gencies, such as pandemics. 
(c) REPORT TO CONGRESS.—Not later than January 
1, 2021, the Secretary shall— 
(1) submit a report to the Committee Energy 
and Commerce of the House of Representatives and 
the Committee on Health, Education, Labor and 
Pensions of the Senate regarding the improved, 
transparent processes developed under this section; 
and 
(2) include in such report recommendations for 
opportunities for communication (by telebriefing, 
phone calls, or in-person meetings) between the Sec-
retary and States, localities, Tribes, and territories 
regarding such improved, transparent processes. 
GAO STUDY ON THE FEASIBILITY AND BENEFITS OF A 
STRATEGIC NATIONAL STOCKPILE USER FEE AGREEMENT 
SEC. 30536. 
(a) IN GENERAL.— The Comptroller General of the 
United States shall conduct a study to investigate the fea-
sibility of establishing user fees to offset certain Federal 
costs attributable to the procurement of single-source ma-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00485
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
486 
terials for the Strategic National Stockpile under section 
319F–2 of the Public Health Service Act (42 U.S.C. 
247d–6b) and distributions of such materials from the 
Stockpile. In conducting this study, the Comptroller Gen-
eral shall consider, to the extent information is available— 
(1) whether entities receiving such distributions 
generate profits from those distributions; 
(2) any Federal costs attributable to such dis-
tributions; 
(3) whether such user fees would provide the 
Secretary with funding to potentially offset procure-
ment costs of such materials for the Strategic Na-
tional Stockpile; and 
(4) any other issues the Comptroller General 
identifies as relevant. 
(b) REPORT.—Not later than February 1, 2023, the 
Comptroller General of the United States shall submit to 
the Congress a report on the findings and conclusions of 
the study under subsection (a). 
Subtitle C—Testing and Testing Infrastructure 
Improvements 
COVID–19 TESTING STRATEGY 
SEC. 30541. 
(a) STRATEGY.—Not later than June 15, 2020, the 
Secretary shall update the COVID–19 strategic testing 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00486
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
487 
plan under the heading ‘‘Department of Health and 
Human Services—Office of the Secretary—Public Health 
and Social Service Emergency Fund’’ in title I of division 
B of the Paycheck Protection Program and Health Care 
Enhancement Act (Public Law 116–139, 134 Stat. 620, 
626–627) and submit to the appropriate congressional 
committees such updated national plan identifying— 
(1) what level of, types of, and approaches to 
testing (including predicted numbers of tests, popu-
lations to be tested, and frequency of testing and the 
appropriate setting whether a health care setting 
(such as hospital-based, high-complexity laboratory, 
point-of-care, mobile testing units, pharmacies or 
community health centers) or non-health care setting 
(such as workplaces, schools, or child care centers)) 
are necessary— 
(A) to sufficiently monitor and contribute 
to the control of the transmission of SARS– 
CoV–2 in the United States; 
(B) to ensure that any reduction in social 
distancing efforts, when determined appropriate 
by public health officials, can be undertaken in 
a manner that optimizes the health and safety 
of the people of the United States, and reduces 
disparities (including disparities related to race, 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00487
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
488 
ethnicity, sex, age, disability status, socio-
economic status, and geographic location) in the 
prevalence of, incidence of, and health outcomes 
with respect to, COVID–19; and 
(C) to provide for ongoing surveillance suf-
ficient to support contact tracing, case identi-
fication, quarantine, and isolation to prevent fu-
ture outbreaks of COVID–19; 
(2) specific plans and benchmarks, each with 
clear timelines, to ensure— 
(A) such level of, types of, and approaches 
to testing as are described in paragraph (1), 
with respect to optimizing health and safety; 
(B) sufficient availability of all necessary 
testing materials and supplies, including extrac-
tion and testing kits, reagents, transport media, 
swabs, instruments, analysis equipment, per-
sonal protective equipment if necessary for test-
ing (including point-of-care testing), and other 
equipment; 
(C) allocation of testing materials and sup-
plies in a manner that optimizes public health, 
including by considering the variable impact of 
SARS–CoV–2 on specific States, territories, In-
dian Tribes, Tribal organizations, urban Indian 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00488
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
489 
organizations, communities, industries, and pro-
fessions; 
(D) sufficient evidence of validation for 
tests that are deployed as a part of such strat-
egy; 
(E) sufficient laboratory and analytical ca-
pacity, including target turnaround time for 
test results; 
(F) sufficient personnel, including per-
sonnel to collect testing samples, conduct and 
analyze results, and conduct testing follow-up, 
including contact tracing, as appropriate; and 
(G) enforcement of the Families First 
Coronavirus Response Act (Public Law 116– 
127) to ensure patients who are tested are not 
subject to cost sharing; 
(3) specific plans to ensure adequate testing in 
rural areas, frontier areas, health professional short-
age areas, and medically underserved areas (as de-
fined in section 330I(a) of the Public Health Service 
Act (42 U.S.C. 254c–14(a))), and for underserved 
populations, Native Americans (including Indian 
Tribes, Tribal organizations, and urban Indian orga-
nizations), and populations at increased risk related 
to COVID–19; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00489
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
490 
(4) specific plans to ensure accessibility of test-
ing to people with disabilities, older individuals, and 
individuals with underlying health conditions or 
weakened immune systems; and 
(5) specific plans for broadly developing and 
implementing testing for potential immunity in the 
United States, as appropriate, in a manner suffi-
cient— 
(A) to monitor and contribute to the con-
trol of SARS–CoV–2 in the United States; 
(B) to ensure that any reduction in social 
distancing efforts, when determined appropriate 
by public health officials, can be undertaken in 
a manner that optimizes the health and safety 
of the people of the United States; and 
(C) to reduce disparities (including dispari-
ties related to race, ethnicity, sex, age, dis-
ability status, socioeconomic status, and geo-
graphic location) in the prevalence of, incidence 
of, and health outcomes with respect to, 
COVID–19. 
(b) COORDINATION.—The Secretary shall carry out 
this section— 
(1) in coordination with the Administrator of 
the Federal Emergency Management Agency; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00490
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
491 
(2) in collaboration with other agencies and de-
partments, as appropriate; and 
(3) taking into consideration the State plans for 
COVID–19 testing prepared as required under the 
heading ‘‘Department of Health and Human Serv-
ices—Office of the Secretary—Public Health and 
Social Service Emergency Fund’’ in title I of divi-
sion B of the Paycheck Protection Program and 
Health Care Enhancement Act (Public Law 116– 
139; 134 Stat. 620, 624). 
(c) UPDATES.— 
(1) FREQUENCY.—The updated national plan 
under subsection (a) shall be updated every 30 days 
until the end of the public health emergency first de-
clared by the Secretary under section 319 of the 
Public Health Service Act (42 U.S.C. 247d) on Jan-
uary 31, 2020, with respect to COVID–19. 
(2) RELATION TO OTHER LAW.—Paragraph (1) 
applies in lieu of the requirement (for updates every 
90 days until funds are expended) in the second to 
last proviso under the heading ‘‘Department of 
Health and Human Services—Office of the Sec-
retary—Public Health and Social Service Emergency 
Fund’’ in title I of division B of the Paycheck Pro-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00491
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
492 
tection Program and Health Care Enhancement Act 
(Public Law 116–139; 134 Stat. 620, 627). 
(d) APPROPRIATE CONGRESSIONAL COMMITTEES.— 
In this section, the term ‘‘appropriate congressional com-
mittees’’ means— 
(1) the Committee on Appropriations and the 
Committee on Energy and Commerce of the House 
of Representatives; and 
(2) the Committee on Appropriations and the 
Committee on Health, Education, Labor and Pen-
sions and of the Senate. 
CENTRALIZED TESTING INFORMATION WEBSITE 
SEC. 30542. 
The Secretary shall establish and maintain a public, 
searchable webpage, to be updated and corrected as nec-
essary through a process established by the Secretary, on 
the website of the Department of Health and Human 
Services that— 
(1) identifies all in vitro diagnostic and sero-
logical tests used in the United States to analyze 
clinical specimens for detection of SARS–CoV–2 or 
antibodies specific to SARS–CoV–2, including— 
(A) those tests— 
(i) that are approved, cleared, or au-
thorized under section 510(k), 513, 515, or 
564 of the Federal Food, Drug, and Cos-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00492
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
493 
metic Act (21 U.S.C. 360(k), 360c, 360e, 
360bbb–3); 
(ii) that have been validated by the 
test’s developers for use on clinical speci-
mens and for which the developer has noti-
fied the Food and Drug Administration of 
the developer’s intent to market the test 
consistent with applicable guidance issued 
by the Secretary; or 
(iii) that have been developed and au-
thorized by a State that has notified the 
Secretary of the State’s intention to review 
tests intended to diagnose COVID–19; and 
(B) other SARS–CoV–2-related tests that 
the Secretary determines appropriate in guid-
ance, which may include tests related to the 
monitoring of COVID–19 patient status; 
(2) provides relevant information, as deter-
mined by the Secretary, on each test identified pur-
suant to paragraph (1), which may include— 
(A) the name and contact information of 
the developer of the test; 
(B) the date of receipt of notification by 
the Food and Drug Administration of the devel-
oper’s intent to market the test; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00493
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
494 
(C) the date of authorization for use of the 
test on clinical specimens, where applicable; 
(D) the letter of authorization for use of 
the test on clinical specimens, where applicable; 
(E) any fact sheets, manufacturer instruc-
tions, and package inserts for the test, includ-
ing information on intended use; 
(F) sensitivity and specificity of the test; 
and 
(G) in the case of tests distributed by com-
mercial manufacturers, the number of tests dis-
tributed and, if available, the number of labora-
tories in the United States with the required 
platforms installed to perform the test; and 
(3) includes— 
(A) a list of laboratories certified under 
section 353 of the Public Health Service Act 
(42 U.S.C. 263a; commonly referred to as 
‘‘CLIA’’) that— 
(i) meet the regulatory requirements 
under such section to perform high- or 
moderate-complexity testing; and 
(ii) are authorized to perform SARS– 
CoV–2 diagnostic or serological tests on 
clinical specimens; and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00494
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
495 
(B) information on each laboratory identi-
fied pursuant to subparagraph (A), including— 
(i) the name and address of the lab-
oratory; 
(ii) the CLIA certificate number; 
(iii) the laboratory type; 
(iv) the certificate type; and 
(v) the complexity level. 
MANUFACTURER REPORTING OF TEST DISTRIBUTION 
SEC. 30543. 
(a) IN GENERAL.—A commercial manufacturer of an 
in vitro diagnostic or serological COVID–19 test shall, on 
a weekly basis, submit a notification to the Secretary re-
garding distribution of each such test, which notifica-
tion— 
(1) shall include the number of tests distributed 
and the entities to which the tests are distributed; 
and 
(2) may include the quantity of such tests dis-
tributed by the manufacturer. 
(b) CONFIDENTIALITY.—Nothing in this section shall 
be construed as authorizing the Secretary to disclose any 
information that is a trade secret or confidential informa-
tion subject to section 552(b)(4) of title 5, United States 
Code, or section 1905 of title 18, United States Code. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00495
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
497 
(B) after review of such response, the 
manufacturer had a reasonable basis for not 
notifying as required under subsection (a). 
STATE TESTING REPORT 
SEC. 30544. 
For any State that authorizes (or intends to author-
ize) one or more laboratories in the State to develop and 
perform in vitro diagnostic COVID–19 tests, the head of 
the department or agency of such State with primary re-
sponsibility for health shall— 
(1) notify the Secretary of such authorization 
(or intention to authorize); and 
(2) provide the Secretary with a weekly re-
port— 
(A) identifying all laboratories authorized 
(or intended to be authorized) by the State to 
develop 
and 
perform 
in 
vitro 
diagnostic 
COVID–19 tests; 
(B) including relevant information on all 
laboratories identified pursuant to subpara-
graph (A), which may include information on 
laboratory testing capacity; 
(C) identifying all in vitro diagnostic 
COVID–19 tests developed and approved for 
clinical use in laboratories identified pursuant 
to subparagraph (A); and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00497
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
498 
(D) including relevant information on all 
tests identified pursuant to subparagraph (C), 
which may include— 
(i) the name and contact information 
of the developer of any such test; 
(ii) any fact sheets, manufacturer in-
structions, and package inserts for any 
such test, including information on in-
tended use; and 
(iii) the sensitivity and specificity of 
any such test. 
STATE LISTING OF TESTING SITES 
SEC. 30545. 
Not later than 14 days after the date of enactment 
of this Act, any State receiving funding or assistance 
under this Act, as a condition on such receipt, shall estab-
lish and maintain a public, searchable webpage on the offi-
cial website of the State that— 
(1) identifies all sites located in the State that 
provide diagnostic or serological testing for SARS– 
CoV–2; and 
(2) provides appropriate contact information for 
SARS–CoV–2 testing sites pursuant to paragraph 
(1). 
REPORTING OF COVID–19 TESTING RESULTS 
SEC. 30546. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00498
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
499 
(a) IN GENERAL.—Every laboratory that performs or 
analyzes a test that is intended to detect SARS–CoV–2 
or to diagnose a possible case of COVID–19 shall report 
daily the number of tests performed and the results from 
each such test to the Secretary of Health and Human 
Services and to the Secretary of Homeland Security, in 
such form and manner as such Secretaries may prescribe. 
Such information shall be made available to the public in 
a searchable, electronic format. 
(b) ADDITIONAL REPORTING REQUIREMENTS.—The 
Secretaries specified in subsection (a)— 
(1) may specify additional reporting require-
ments under this section by regulation, including by 
interim final rule, or by guidance; and 
(2) may issue such regulations or guidance 
without regard to the procedures otherwise required 
by section 553 of title 5, United States Code. 
GAO REPORT ON DIAGNOSTIC TESTS 
SEC. 30547. 
(a) GAO STUDY.—Not later than 18 months after 
the date of enactment of this Act, the Comptroller General 
of the United States shall submit to the Committee on 
Energy and Commerce of the House of Representatives 
and the Committee on Health, Education, Labor and Pen-
sions of the Senate a report describing the response of 
entities described in subsection (b) to the COVID–19 pan-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00499
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
500 
demic with respect to the development, regulatory evalua-
tion, and deployment of diagnostic tests. 
(b) ENTITIES DESCRIBED.—Entities described in 
this subsection include— 
(1) laboratories, including public health, aca-
demic, clinical, and commercial laboratories; 
(2) diagnostic test manufacturers; 
(3) State, local, Tribal, and territorial govern-
ments; and 
(4) the Food and Drug Administration, the 
Centers for Disease Control and Prevention, the 
Centers for Medicare & Medicaid Services, the Na-
tional Institutes of Health, and other relevant Fed-
eral agencies, as appropriate. 
(c) CONTENTS.—The report under subsection (a) 
shall include— 
(1) a description of actions taken by entities de-
scribed in subsection (b) to develop, evaluate, and 
deploy diagnostic tests; 
(2) an assessment of the coordination of Fed-
eral agencies in the development, regulatory evalua-
tion, and deployment of diagnostic tests; 
(3) an assessment of the standards used by the 
Food and Drug Administration to evaluate diag-
nostic tests; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00500
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
501 
(4) an assessment of the clarity of Federal 
agency guidance related to testing, including the 
ability for individuals without medical training to 
understand which diagnostic tests had been evalu-
ated by the Food and Drug Administration; 
(5) a description of— 
(A) actions taken and clinical processes 
employed by States and territories that have 
authorized laboratories to develop and perform 
diagnostic tests not authorized, approved, or 
cleared by the Food and Drug Administration, 
including actions of such States and territories 
to evaluate the accuracy and sensitivity of such 
tests; and 
(B) the standards used by States and ter-
ritories when deciding when to authorize labora-
tories to develop or perform diagnostic tests; 
(6) an assessment of the steps taken by labora-
tories and diagnostic test manufacturers to validate 
diagnostic tests, as well as the evidence collected by 
such entities to support validation; and 
(7) based on available reports, an assessment of 
the accuracy and sensitivity of a representative sam-
ple of available diagnostic tests. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00501
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
502 
(d) DEFINITION.—In this section, the term ‘‘diag-
nostic test’’ means an in vitro diagnostic product (as de-
fined in section 809.3(a) of title 21, Code of Federal Regu-
lations) for— 
(1) the detection of SARS–CoV–2; 
(2) the diagnosis of the virus that causes 
COVID–19; or 
(3) the detection of antibodies specific to 
SARS–CoV–2, such as a serological test. 
PUBLIC HEALTH DATA SYSTEM TRANSFORMATION 
SEC. 30548. 
Subtitle C of title XXVIII of the Public Health Serv-
ice Act (42 U.S.C. 300hh–31 et seq.) is amended by add-
ing at the end the following: 
‘‘SEC. 
2822. 
PUBLIC 
HEALTH 
DATA 
SYSTEM 
TRANS-
FORMATION. 
‘‘(a) EXPANDING CDC AND PUBLIC HEALTH DE-
PARTMENT CAPABILITIES.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall— 
‘‘(A) conduct activities to expand, enhance, 
and improve applicable public health data sys-
tems used by the Centers for Disease Control 
and Prevention, related to the interoperability 
and improvement of such systems (including as 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00502
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
504 
simplifying and supporting reporting by 
health care providers, as applicable, pursu-
ant to State law, including through the use 
of health information technology; 
‘‘(iv) enhancing the interoperability of 
public health data systems (including sys-
tems created or accessed by public health 
departments) with health information tech-
nology, including with health information 
technology 
certified 
under 
section 
3001(c)(5); 
‘‘(v) supporting and training data sys-
tems, data science, and informatics per-
sonnel; 
‘‘(vi) supporting earlier disease and 
health condition detection, such as through 
near real-time data monitoring, to support 
rapid public health responses; 
‘‘(vii) supporting activities within the 
applicable jurisdiction related to the expan-
sion and modernization of electronic case 
reporting; and 
‘‘(viii) developing and disseminating 
information related to the use and impor-
tance of public health data. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00504
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
505 
‘‘(2) DATA STANDARDS.—In carrying out para-
graph (1), the Secretary, acting through the Direc-
tor of the Centers for Disease Control and Preven-
tion, shall, as appropriate and in consultation with 
the Office of the National Coordinator for Health 
Information Technology, designate data and tech-
nology standards (including standards for interoper-
ability) for public health data systems, with def-
erence given to standards published by consensus- 
based standards development organizations with 
public input and voluntary consensus-based stand-
ards bodies. 
‘‘(3) 
PUBLIC-PRIVATE
PARTNERSHIPS.—The 
Secretary may develop and utilize public-private 
partnerships for technical assistance, training, and 
related implementation support for State, local, 
Tribal, and territorial public health departments, 
and the Centers for Disease Control and Prevention, 
on the expansion and modernization of electronic 
case reporting and public health data systems, as 
applicable. 
‘‘(b) REQUIREMENTS.— 
‘‘(1) 
HEALTH
INFORMATION
TECHNOLOGY 
STANDARDS.—The Secretary may not award a grant 
or cooperative agreement under subsection (a)(1)(B) 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00505
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
506 
unless the applicant uses or agrees to use standards 
endorsed by the National Coordinator for Health In-
formation 
Technology 
pursuant 
to 
section 
3001(c)(1) or adopted by the Secretary under sec-
tion 3004. 
‘‘(2) WAIVER.—The Secretary may waive the 
requirement under paragraph (1) with respect to an 
applicant if the Secretary determines that the activi-
ties under subsection (a)(1)(B) cannot otherwise be 
carried out within the applicable jurisdiction. 
‘‘(3) APPLICATION.—A State, local, Tribal, or 
territorial health department applying for a grant or 
cooperative agreement under this section shall sub-
mit an application to the Secretary at such time and 
in such manner as the Secretary may require. Such 
application shall include information describing— 
‘‘(A) the activities that will be supported 
by the grant or cooperative agreement; and 
‘‘(B) how the modernization of the public 
health data systems involved will support or im-
pact the public health infrastructure of the 
health department, including a description of 
remaining gaps, if any, and the actions needed 
to address such gaps. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00506
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
507 
‘‘(c) STRATEGY AND IMPLEMENTATION PLAN.—Not 
later than 180 days after the date of enactment of this 
section, the Secretary, acting through the Director of the 
Centers for Disease Control and Prevention, shall submit 
to the Committee on Health, Education, Labor and Pen-
sions of the Senate and the Committee on Energy and 
Commerce of the House of Representatives a coordinated 
strategy and an accompanying implementation plan that 
identifies and demonstrates the measures the Secretary 
will utilize to— 
‘‘(1) update and improve applicable public 
health data systems used by the Centers for Disease 
Control and Prevention; and 
‘‘(2) carry out the activities described in this 
section to support the improvement of State, local, 
Tribal, and territorial public health data systems. 
‘‘(d) 
CONSULTATION.—The 
Secretary, 
acting 
through the Director of the Centers for Disease Control 
and Prevention, shall consult with State, local, Tribal, and 
territorial health departments, professional medical and 
public health associations, associations representing hos-
pitals or other health care entities, health information 
technology experts, and other appropriate public or private 
entities regarding the plan and grant program to mod-
ernize public health data systems pursuant to this section. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00507
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
508 
Activities under this subsection may include the provision 
of technical assistance and training related to the ex-
change of information by such public health data systems 
used by relevant health care and public health entities at 
the local, State, Federal, Tribal, and territorial levels, and 
the development and utilization of public-private partner-
ships for implementation support applicable to this sec-
tion. 
‘‘(e) REPORT TO CONGRESS.—Not later than 1 year 
after the date of enactment of this section, the Secretary 
shall submit a report to the Committee on Health, Edu-
cation, Labor and Pensions of the Senate and the Com-
mittee on Energy and Commerce of the House of Rep-
resentatives that includes— 
‘‘(1) a description of any barriers to— 
‘‘(A) public health authorities imple-
menting interoperable public health data sys-
tems and electronic case reporting; 
‘‘(B) the exchange of information pursuant 
to electronic case reporting; or 
‘‘(C) reporting by health care providers 
using such public health data systems, as ap-
propriate, and pursuant to State law; 
‘‘(2) an assessment of the potential public 
health impact of implementing electronic case re-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00508
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
509 
porting and interoperable public health data sys-
tems; and 
‘‘(3) a description of the activities carried out 
pursuant to this section. 
‘‘(f) ELECTRONIC CASE REPORTING.—In this sec-
tion, the term ‘electronic case reporting’ means the auto-
mated identification, generation, and bilateral exchange of 
reports of health events among electronic health record or 
health information technology systems and public health 
authorities. 
‘‘(g) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there are authorized to be appro-
priated $450,000,000 to remain available until ex-
pended.’’. 
PILOT PROGRAM TO IMPROVE LABORATORY 
INFRASTRUCTURE 
SEC. 30549. 
(a) IN GENERAL.—The Secretary shall award grants 
to States and political subdivisions of States to support 
the improvement, renovation, or modernization of infra-
structure at clinical laboratories (as defined in section 353 
of the Public Health Service Act (42 U.S.C. 263a)) that 
will help to improve SARS–CoV–2 and COVID–19 testing 
and response activities, including the expansion and en-
hancement of testing capacity at such laboratories. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00509
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
510 
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$1,000,000,000 to remain available until expended. 
CORE
PUBLIC
HEALTH
INFRASTRUCTURE
FOR
STATE, 
LOCAL, TRIBAL, AND
TERRITORIAL
HEALTH
DE-
PARTMENTS 
SEC. 30550. 
(a) PROGRAM.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall establish a core public health infrastructure 
program consisting of awarding grants under subsection 
(b). 
(b) GRANTS.— 
(1) AWARD.—For the purpose of addressing 
core public health infrastructure needs, the Sec-
retary— 
(A) shall award a grant to each State 
health department; and 
(B) may award grants on a competitive 
basis to State, local, Tribal, or territorial health 
departments. 
(2) ALLOCATION.—Of the total amount of 
funds awarded as grants under this subsection for a 
fiscal year— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00510
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
511 
(A) not less than 50 percent shall be for 
grants to State health departments under para-
graph (1)(A); and 
(B) not less than 30 percent shall be for 
grants to State, local, Tribal, or territorial 
health departments under paragraph (1)(B). 
(c) USE OF FUNDS.—A State, local, Tribal, or terri-
torial health department receiving a grant under sub-
section (b) shall use the grant funds to address core public 
health infrastructure needs, including those identified in 
the accreditation process under subsection (g). 
(d) FORMULA GRANTS TO STATE HEALTH DEPART-
MENTS.—In making grants under subsection (b)(1)(A), 
the Secretary shall award funds to each State health de-
partment in accordance with— 
(1) a formula based on population size; burden 
of preventable disease and disability; and core public 
health infrastructure gaps, including those identified 
in the accreditation process under subsection (g); 
and 
(2) application requirements established by the 
Secretary, including a requirement that the State 
health department submit a plan that demonstrates 
to the satisfaction of the Secretary that the State’s 
health department will— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00511
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
512 
(A) address its highest priority core public 
health infrastructure needs; and 
(B) as appropriate, allocate funds to local 
health departments within the State. 
(e) COMPETITIVE GRANTS TO STATE, LOCAL, TRIB-
AL, AND
TERRITORIAL
HEALTH
DEPARTMENTS.—In 
making grants under subsection (b)(1)(B), the Secretary 
shall give priority to applicants demonstrating core public 
health infrastructure needs identified in the accreditation 
process under subsection (g). 
(f) MAINTENANCE OF EFFORT.—The Secretary may 
award a grant to an entity under subsection (b) only if 
the entity demonstrates to the satisfaction of the Sec-
retary that— 
(1) funds received through the grant will be ex-
pended only to supplement, and not supplant, non- 
Federal and Federal funds otherwise available to the 
entity for the purpose of addressing core public 
health infrastructure needs; and 
(2) with respect to activities for which the grant 
is awarded, the entity will maintain expenditures of 
non-Federal amounts for such activities at a level 
not less than the level of such expenditures main-
tained by the entity for the fiscal year preceding the 
fiscal year for which the entity receives the grant. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00512
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
513 
(g) ESTABLISHMENT OF A PUBLIC HEALTH ACCRED-
ITATION PROGRAM.— 
(1) IN GENERAL.—The Secretary shall— 
(A) develop, and periodically review and 
update, standards for voluntary accreditation of 
State, local, Tribal, and territorial health de-
partments and public health laboratories for the 
purpose of advancing the quality and perform-
ance of such departments and laboratories; and 
(B) implement a program to accredit such 
health departments and laboratories in accord-
ance with such standards. 
(2) COOPERATIVE AGREEMENT.—The Secretary 
may enter into a cooperative agreement with a pri-
vate nonprofit entity to carry out paragraph (1). 
(h) REPORT.—The Secretary shall submit to the Con-
gress an annual report on progress being made to accredit 
entities under subsection (g), including— 
(1) a strategy, including goals and objectives, 
for accrediting entities under subsection (g) and 
achieving the purpose described in subsection 
(g)(1)(A); 
(2) identification of gaps in research related to 
core public health infrastructure; and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00513
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
514 
(3) recommendations of priority areas for such 
research. 
(i) DEFINITION.—In this section, the term ‘‘core pub-
lic health infrastructure’’ includes— 
(1) workforce capacity and competency; 
(2) laboratory systems; 
(3) testing capacity, including test platforms, 
mobile testing units, and personnel; 
(4) health information, health information sys-
tems, and health information analysis; 
(5) disease surveillance; 
(6) contact tracing; 
(7) communications; 
(8) financing; 
(9) other relevant components of organizational 
capacity; and 
(10) other related activities. 
(j) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there are authorized to be appropriated 
$6,000,000,000, to remain available until expended. 
CORE PUBLIC HEALTH INFRASTRUCTURE AND ACTIVITIES 
FOR CDC 
SEC. 30551. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall expand and improve the core public health in-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00514
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
515 
frastructure and activities of the Centers for Disease Con-
trol and Prevention to address unmet and emerging public 
health needs. 
(b) REPORT.—The Secretary shall submit to the Con-
gress an annual report on the activities funded through 
this section. 
(c) DEFINITION.—In this section, the term ‘‘core 
public health infrastructure’’ has the meaning given to 
such term in section 30550. 
(d) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$1,000,000,000, to remain available until expended. 
Subtitle D—COVID–19 National Testing and Contact 
Tracing Initiative 
NATIONAL
SYSTEM
FOR
COVID–19
TESTING, CONTACT 
TRACING, SURVEILLANCE, CONTAINMENT, AND MITI-
GATION 
SEC. 30561. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, and in coordination with State, local, Tribal, and ter-
ritorial health departments, shall establish and implement 
a nationwide evidence-based system for— 
(1) testing, contact tracing, surveillance, con-
tainment, and mitigation with respect to COVID–19; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00515
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
516 
(2) offering guidance on voluntary isolation and 
quarantine of individuals infected with, or exposed to 
individuals infected with, the virus that causes 
COVID–19; and 
(3) public reporting on testing, contact tracing, 
surveillance, and voluntary isolation and quarantine 
activities with respect to COVID–19. 
(b) COORDINATION; TECHNICAL ASSISTANCE.—In 
carrying out the national system under this section, the 
Secretary shall— 
(1) coordinate State, local, Tribal, and terri-
torial activities related to testing, contact tracing, 
surveillance, containment, and mitigation with re-
spect to COVID–19, as appropriate; and 
(2) provide technical assistance for such activi-
ties, as appropriate. 
(c) CONSIDERATION.—In establishing and imple-
menting the national system under this section, the Sec-
retary shall take into consideration— 
(1) the State plans referred to in the heading 
‘‘Public Health and Social Services Emergency 
Fund’’ in title I of division B of the Paycheck Pro-
tection Program and Health Care Enhancement Act 
(Public Law 116–139); and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00516
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
517 
(2) the testing strategy submitted under section 
30541. 
(d) REPORTING.—The Secretary shall— 
(1) not later than December 31, 2020, submit 
to the Committee on Energy and Commerce of the 
House of Representatives and the Committee on 
Health, Education, Labor and Pensions a prelimi-
nary report on the effectiveness of the activities car-
ried out pursuant to this subtitle; and 
(2) not later than December 21, 2021, submit 
to such committees a final report on such effective-
ness. 
GRANTS 
SEC. 30562. 
(a) IN GENERAL.—To implement the national system 
under section 30561, the Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall, subject to the availability of appropriations, 
award grants to State, local, Tribal, and territorial health 
departments that seek grants under this section to carry 
out coordinated testing, contact tracing, surveillance, con-
tainment, and mitigation with respect to COVID–19, in-
cluding— 
(1) diagnostic and surveillance testing and re-
porting; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00517
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
518 
(2) community-based contact tracing efforts; 
and 
(3) policies related to voluntary isolation and 
quarantine of individuals infected with, or exposed to 
individuals infected with, the virus that causes 
COVID–19. 
(b) FLEXIBILITY.—The Secretary shall ensure that— 
(1) the grants under subsection (a) provide 
flexibility for State, local, Tribal, and territorial 
health departments to modify, establish, or maintain 
evidence-based systems; and 
(2) local health departments receive funding 
from State health departments or directly from the 
Centers for Disease Control and Prevention to con-
tribute to such systems, as appropriate. 
(c) ALLOCATIONS.— 
(1) FORMULA.—The Secretary, acting through 
the Director of the Centers for Disease Control and 
Prevention, shall allocate amounts made available 
pursuant to subsection (a) in accordance with a for-
mula to be established by the Secretary that pro-
vides a minimum level of funding to each State, 
local, Tribal, and territorial health department that 
seeks a grant under this section and allocates addi-
tional funding based on the following prioritization: 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00518
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
519 
(A) The Secretary shall give highest pri-
ority to applicants proposing to serve popu-
lations in one or more geographic regions with 
a high burden of COVID–19 based on data pro-
vided by the Centers for Disease Control and 
Prevention, or other sources as determined by 
the Secretary. 
(B) The Secretary shall give second high-
est priority to applicants preparing for, or cur-
rently working to mitigate, a COVID–19 surge 
in a geographic region that does not yet have 
a high number of reported cases of COVID–19 
based on data provided by the Centers for Dis-
ease Control and Prevention, or other sources 
as determined by the Secretary. 
(C) The Secretary shall give third highest 
priority to applicants proposing to serve high 
numbers of low-income and uninsured popu-
lations, including medically underserved popu-
lations (as defined in section 330(b)(3) of the 
Public 
Health 
Service 
Act 
(42 
U.S.C. 
254b(b)(3))), health professional shortage areas 
(as defined under section 332(a) of the Public 
Health Service Act (42 U.S.C. 254e(a))), racial 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00519
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
520 
and ethnic minorities, or geographically diverse 
areas, as determined by the Secretary. 
(2) NOTIFICATION.—Not later than the date 
that is one week before first awarding grants under 
this section, the Secretary shall submit to the Com-
mittee on Energy and Commerce of the House of 
Representatives and the Committee on Health, Edu-
cation, Labor and Pensions of the Senate a notifica-
tion detailing the formula established under para-
graph (1) for allocating amounts made available pur-
suant to subsection (a). 
(d) USE OF FUNDS.—A State, local, Tribal, and ter-
ritorial health department receiving a grant under this 
section shall, to the extent possible, use the grant funds 
for the following activities, or other activities deemed ap-
propriate by the Director of the Centers for Disease Con-
trol and Prevention: 
(1) TESTING.—To implement a coordinated 
testing system that— 
(A) leverages or modernizes existing test-
ing infrastructure and capacity; 
(B) is consistent with the updated testing 
strategy required under section 30541; 
(C) is coordinated with the State plan for 
COVID–19 testing prepared as required under 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00520
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
521 
the heading ‘‘Department of Health and 
Human Services—Office of the Secretary— 
Public Health and Social Service Emergency 
Fund’’ in title I of division B of the Paycheck 
Protection Program and Health Care Enhance-
ment Act (Public Law 116–139; 134 Stat. 620, 
624); 
(D) is informed by contact tracing and 
surveillance activities under this subtitle; 
(E) is informed by guidelines established 
by the Centers for Disease Control and Preven-
tion for which populations should be tested; 
(F) identifies how diagnostic and sero-
logical tests in such system shall be validated 
prior to use; 
(G) identifies how diagnostic and sero-
logical tests and testing supplies will be distrib-
uted to implement such system; 
(H) identifies specific strategies for ensur-
ing testing capabilities and accessibility in 
medically underserved populations (as defined 
in section 330(b)(3) of the Public Health Serv-
ice Act (42 U.S.C. 254b(b)(3))), health profes-
sional shortage areas (as defined under section 
332(a) of the Public Health Service Act (42 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00521
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
522 
U.S.C. 254e(a))), racial and ethnic minority 
populations, and geographically diverse areas, 
as determined by the Secretary; 
(I) identifies how testing may be used, and 
results may be reported, in both health care set-
tings (such as hospitals, laboratories for mod-
erate or high-complexity testing, pharmacies, 
mobile testing units, and community health cen-
ters) and non-health care settings (such as 
workplaces, schools, childcare centers, or drive- 
throughs); 
(J) allows for testing in sentinel surveil-
lance programs, as appropriate; and 
(K) supports the procurement and dis-
tribution of diagnostic and serological tests and 
testing supplies to meet the goals of the system. 
(2) CONTACT TRACING.—To implement a co-
ordinated contact tracing system that— 
(A) leverages or modernizes existing con-
tact tracing systems and capabilities, including 
community health workers, health departments, 
and Federally qualified health centers; 
(B) is able to investigate cases of COVID– 
19, and help to identify other potential cases of 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00522
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
523 
COVID–19, through tracing contacts of individ-
uals with positive diagnoses; 
(C) establishes culturally competent and 
multilingual strategies for contact tracing, 
which may include consultation with and sup-
port for cultural or civic organizations with es-
tablished ties to the community; 
(D) provides individuals identified under 
the contact tracing program with information 
and support for containment or mitigation; 
(E) enables State, local, Tribal, and terri-
torial health departments to work with a non-
governmental, community partner or partners 
and State and local workforce development sys-
tems (as defined in section 3(67) of Workforce 
Innovation and Opportunity Act (29 U.S.C. 
3102(67))) receiving grants under section 
30566(b) of this Act to hire and compensate a 
locally-sourced contact tracing workforce, if 
necessary, to supplement the public health 
workforce, to— 
(i) identify the number of contact 
tracers needed for the respective State, lo-
cality, territorial, or Tribal health depart-
ment to identify all cases of COVID–19 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00523
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
524 
currently in the jurisdiction and those an-
ticipated to emerge over the next 18 
months in such jurisdiction; 
(ii) outline qualifications necessary for 
contact tracers; 
(iii) train the existing and newly hired 
public health workforce on best practices 
related to tracing close contacts of individ-
uals diagnosed with COVID–19, including 
the protection of individual privacy and cy-
bersecurity protection; and 
(iv) equip the public health workforce 
with tools and resources to enable a rapid 
response to new cases; 
(F) identifies the level of contact tracing 
needed within the State, locality, territory, or 
Tribal area to contain and mitigate the trans-
mission of COVID–19; 
(G) establishes statewide mechanisms to 
integrate regular evaluation to the Centers for 
Disease Control and Prevention regarding con-
tact tracing efforts, makes such evaluation pub-
licly available, and to the extent possible pro-
vides for such evaluation at the county level; 
and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00524
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
525 
(H) identifies specific strategies for ensur-
ing contact tracing activities in medically un-
derserved populations (as defined in section 
330(b)(3) of the Public Health Service Act (42 
U.S.C. 254b(b)(3))), health professional short-
age areas (as defined under section 332(a) of 
the Public Health Service Act (42 U.S.C. 
254e(a))), racial and ethnic minority popu-
lations, and geographically diverse areas, as de-
termined by the Secretary. 
(3) SURVEILLANCE.—To strengthen the exist-
ing public health surveillance system that— 
(A) leverages or modernizes existing sur-
veillance systems within the respective State, 
local, Tribal, or territorial health department 
and national surveillance systems; 
(B) detects and identifies trends in 
COVID–19 at the county level; 
(C) evaluates State, local, Tribal, and ter-
ritorial health departments in achieving surveil-
lance capabilities with respect to COVID–19; 
(D) integrates and improves disease sur-
veillance and immunization tracking; and 
(E) identifies specific strategies for ensur-
ing disease surveillance in medically under-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00525
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
526 
served populations (as defined in section 
330(b)(3) of the Public Health Service Act (42 
U.S.C. 254b(b)(3))), health professional short-
age areas (as defined under section 332(a) of 
the Public Health Service Act (42 U.S.C. 
254e(a))), racial and ethnic minority popu-
lations, and geographically diverse areas, as de-
termined by the Secretary. 
(4) CONTAINMENT AND MITIGATION.—To im-
plement a coordinated containment and mitigation 
system that— 
(A) leverages or modernizes existing con-
tainment and mitigation strategies within the 
respective State, local, Tribal, or territorial gov-
ernments and national containment and mitiga-
tion strategies; 
(B) may provide for, connect to, and lever-
age existing social services and support for indi-
viduals who have been infected with or exposed 
to COVID–19 and who are isolated or quar-
antined in their homes, such as through— 
(i) food assistance programs; 
(ii) guidance for household infection 
control; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00526
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
527 
(iii) information and assistance with 
childcare services; and 
(iv) information and assistance per-
taining to support available under the 
CARES Act (Public Law 116–136) and 
this Act; 
(C) provides guidance on the establishment 
of safe, high-quality, facilities for the voluntary 
isolation of individuals infected with, or quar-
antine of the contacts of individuals exposed to 
COVID–19, where hospitalization is not re-
quired, which facilities should— 
(i) be prohibited from making inquir-
ies relating to the citizenship status of an 
individual isolated or quarantined; and 
(ii) be operated by a non-Federal, 
community partner or partners that— 
(I) have previously established re-
lationships in localities; 
(II) work with local places of 
worship, community centers, medical 
facilities, and schools to recruit local 
staff for such facilities; and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00527
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
528 
(III) are fully integrated into 
State, local, Tribal, or territorial con-
tainment and mitigation efforts; and 
(D) identifies specific strategies for ensur-
ing containment and mitigation activities in 
medically underserved populations (as defined 
in section 330(b)(3) of the Public Health Serv-
ice Act (42 U.S.C. 254b(b)(3))), health profes-
sional shortage areas (as defined under section 
332(a) of the Public Health Service Act (42 
U.S.C. 254e(a))), racial and ethnic minority 
populations, and geographically diverse areas, 
as determined by the Secretary. 
(e) REPORTING.—The Secretary shall facilitate 
mechanisms for timely, standardized reporting by grantees 
under this section regarding implementation of the sys-
tems established under this section and coordinated proc-
esses with the reporting as required and under the heading 
‘‘Department of Health and Human Services—Office of 
the Secretary—Public Health and Social Service Emer-
gency Fund’’ in title I of division B of the Paycheck Pro-
tection Program and Health Care Enhancement Act (Pub-
lic Law 116–139, 134 Stat. 620), including— 
(1) a summary of county or local health depart-
ment level information from the States receiving 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00528
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
529 
funding, and information from directly funded local-
ities, territories, and Tribal entities, about the activi-
ties that will be undertaken using funding awarded 
under this section, including subgrants; 
(2) any anticipated shortages of required mate-
rials for testing for COVID–19 under subsection (a); 
and 
(3) other barriers in the prevention, mitigation, 
or treatment of COVID–19 under this section. 
(f) PUBLIC LISTING OF AWARDS.—The Secretary 
shall— 
(1) not later than 7 days after first awarding 
grants under this section, post in a searchable, elec-
tronic format a list of all awards made by the Sec-
retary under this section, including the recipients 
and amounts of such awards; and 
(2) update such list not less than every 7 days 
until all funds made available to carry out this sec-
tion are expended. 
GUIDANCE, TECHNICAL ASSISTANCE, INFORMATION, AND 
COMMUNICATION 
SEC. 30563. 
(a) IN GENERAL.— Not later than 14 days after the 
date of the enactment of this Act, the Secretary, in coordi-
nation with other Federal agencies, as appropriate, shall 
issue guidance, provide technical assistance, and provide 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00529
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
530 
information to States, localities, Tribes, and territories, 
with respect to the following: 
(1) The diagnostic and serological testing of in-
dividuals identified through contact tracing for 
COVID–19, including information with respect to 
the reduction of duplication related to programmatic 
activities, reporting, and billing. 
(2) Best practices regarding contact tracing, in-
cluding the collection of data with respect to such 
contact tracing and requirements related to the 
standardization of demographic and syndromic infor-
mation collected as part of contact tracing efforts. 
(3) Best practices regarding COVID–19 disease 
surveillance, including best practices to reduce dupli-
cation in surveillance activities, identifying gaps in 
surveillance and surveillance systems, and ways in 
which the Secretary plans to effectively support 
State, local, Tribal and territorial health depart-
ments in addressing such gaps. 
(4) Information on ways for State, local, Tribal, 
and territorial health departments to establish and 
maintain the testing, contact tracing, and surveil-
lance activities described in paragraphs (1) through 
(3). 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00530
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
531 
(5) The protection of any personally identifiable 
health information collected pursuant to this sub-
title. 
(6) Best practices regarding privacy and cyber-
security protection related to contact tracing, con-
tainment, and mitigation efforts. 
(b) GUIDANCE ON PAYMENT.—Not later than 14 
days after the date of the enactment of this Act, the Sec-
retary, in coordination with the Administrator of the Cen-
ters for Medicare & Medicaid Services, the Director of the 
Centers for Disease Control and Prevention, and in coordi-
nation with other Federal agencies, as appropriate, shall 
develop and issue to State, local, Tribal, and territorial 
health departments clear guidance and policies— 
(1) with respect to the coordination of claims 
submitted for payment out of the Public Health and 
Social Services Emergency Fund for services fur-
nished 
in 
a 
facility 
referred 
to 
in 
section 
30562(d)(4)(C); 
(2) identifying how an individual who is isolated 
or quarantined at home or in such a facility— 
(A) incurs no out-of-pocket costs for any 
services furnished to such individual while iso-
lated; and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00531
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
532 
(B) may receive income support for lost 
earnings or payments for expenses such as child 
care or elder care while such individual is iso-
lated at home or in such a facility; 
(3) providing information and assistance per-
taining to support available under the CARES Act 
(Public Law 116–136) and this Act; and 
(4) identifying State, local, Tribal, and terri-
torial health departments or partner agencies that 
may provide social support services, such as gro-
ceries or meals, health education, internet access, 
and behavioral health services, to individuals who 
isolated or quarantined at home or in such a facility. 
(c) GUIDANCE ON TESTING.—Not later than 14 days 
after the date of the enactment of this Act, the Secretary, 
in coordination with the Commissioner of Food and 
Drugs, the Director of the National Institutes of Health, 
and the Director of the Centers for Disease Control and 
Prevention, and in coordination with other Federal agen-
cies as appropriate, shall develop and issue to State, local, 
Tribal, and territorial health departments clear guidance 
and policies regarding— 
(1) objective standards to characterize the per-
formance of all diagnostic and serological tests for 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00532
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
533 
COVID–19 in order to independently evaluate tests 
continuously over time; 
(2) protocols for the evaluation of the perform-
ance of diagnostic and serological tests for COVID– 
19; and 
(3) a repository of characterized specimens to 
use to evaluate the performance of those tests that 
can be made available for appropriate entities to use 
to evaluate performance. 
(d) COMMUNICATION.—The Secretary shall identify 
and publicly announce the form and manner for commu-
nication with State, local, Tribal, and territorial health de-
partments for purposes of carrying out the activities ad-
dressed by guidance issued under subsections (a) and (b). 
(e) AVAILABILITY TO PROVIDERS.—Guidance issued 
under subsection (a)(1) shall be issued to health care pro-
viders. 
(f) ONGOING PROVISION OF GUIDANCE AND TECH-
NICAL ASSISTANCE.—Notwithstanding whether funds are 
available specifically to carry out this subtitle, guidance 
and technical assistance shall continue to be provided 
under this section. 
RESEARCH AND DEVELOPMENT 
SEC. 30564. 
The Secretary, in coordination with the Director of 
the Centers for Disease Control and Prevention and in col-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00533
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
534 
laboration with the Director of the National Institutes of 
Health, the Director of the Agency for Healthcare Re-
search and Quality, the Commissioner of Food and Drugs, 
and the Administrator of the Centers for Medicare & Med-
icaid Services, shall support research and development on 
more efficient and effective strategies— 
(1) for the surveillance of SARS–CoV–2 and 
COVID–19; 
(2) for the testing and identification of individ-
uals infected with COVID–19; and 
(3) for the tracing of contacts of individuals in-
fected with COVID–19. 
AWARENESS CAMPAIGNS 
SEC. 30565. 
The Secretary, acting through the Director of the 
Centers for Disease Control and Prevention and in coordi-
nation with other offices and agencies, as appropriate, 
shall award competitive grants or contracts to one or more 
public or private entities, including faith-based organiza-
tions, to carry out multilingual and culturally appropriate 
awareness campaigns. Such campaigns shall— 
(1) be based on available scientific evidence; 
(2) increase awareness and knowledge of 
COVID–19, including countering stigma associated 
with COVID–19; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00534
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
535 
(3) improve information on the availability of 
COVID–19 diagnostic testing; and 
(4) promote cooperation with contact tracing ef-
forts. 
GRANTS TO STATE AND TRIBAL WORKFORCE AGENCIES 
SEC. 30566. 
(a) DEFINITIONS.—In this section: 
(1) IN
GENERAL.—Except as otherwise pro-
vided, the terms in this section have the meanings 
given the terms in section 3 of the Workforce Inno-
vation and Opportunity Act (29 U.S.C. 3102). 
(2) APPRENTICESHIP; APPRENTICESHIP
PRO-
GRAM.—The term ‘‘apprenticeship’’ or ‘‘apprentice-
ship program’’ means an apprenticeship program 
registered under the Act of August 16, 1937 (com-
monly known as the ‘‘National Apprenticeship Act’’) 
(50 Stat. 664, chapter 663; 29 U.S.C. 50 et seq.), 
including any requirement, standard, or rule promul-
gated under such Act, as such requirement, stand-
ard, or rule was in effect on December 30, 2019. 
(3) CONTACT
TRACING
AND
RELATED
POSI-
TIONS.—The term ‘‘contact tracing and related posi-
tions’’ means employment related to contact tracing, 
surveillance, containment, and mitigation activities 
as described in paragraphs (2), (3), and (4) of sec-
tion 30562(d). 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00535
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
536 
(4) ELIGIBLE ENTITY.—The term ‘‘eligible enti-
ty’’ means— 
(A) a State or territory, including the Dis-
trict of Columbia and Puerto Rico; 
(B) an Indian Tribe, Tribal organization, 
Alaska Native entity, Indian-controlled organi-
zations serving Indians, or Native Hawaiian or-
ganizations; 
(C) an outlying area; or 
(D) a local board, if an eligible entity 
under subparagraphs (A) through (C) has not 
applied with respect to the area over which the 
local board has jurisdiction as of the date on 
which the local board submits an application 
under subsection (c). 
(5) ELIGIBLE
INDIVIDUAL.—Notwithstanding 
section 170(b)(2) of the Workforce Innovation and 
Opportunity Act (29 U.S.C. 3225(b)(2)), the term 
‘‘eligible individual’’ means an individual seeking or 
securing employment in contact tracing or related 
positions and is served by an eligible entity or com-
munity-based organization receiving funding under 
this section. 
(6) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of Labor. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00536
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
537 
(b) GRANTS.— 
(1) IN GENERAL.—Subject to the availability of 
appropriations under subsection (g), the Secretary 
shall award national dislocated worker grants under 
section 170(b)(1)(B) of the Workforce Innovation 
and Opportunity Act (29 U.S.C. 3225(b)(1)(B)) to 
each eligible entity that seeks a grant to assist local 
boards and community-based organizations in car-
rying out activities under subsections (f) and (d), re-
spectively, for the following purposes: 
(A) To support the recruitment, place-
ment, and training, as applicable, of eligible in-
dividuals seeking employment in contact tracing 
and related positions in accordance with the na-
tional system for COVID–19 testing, contact 
tracing, surveillance, containment, and mitiga-
tion established under section 30561. 
(B) To assist with the employment transi-
tion to new employment or education and train-
ing of individuals employed under this section 
in preparation for and upon termination of such 
employment. 
(2) TIMELINE.—The Secretary of Labor shall— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00537
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
538 
(A) issue application requirements under 
subsection (c) not later than 10 days after the 
date of enactment of this section; and 
(B) award grants to an eligible entity 
under paragraph (1) not later than 10 days 
after the date on which the Secretary receives 
an application from such entity. 
(c) GRANT APPLICATION.—An eligible entity apply-
ing for a grant under this section shall submit an applica-
tion to the Secretary, at such time and in such form and 
manner as the Secretary may reasonably require, which 
shall include a description of— 
(1) how the eligible entity will support the re-
cruitment, placement, and training, as applicable, of 
eligible individuals seeking employment in contact 
tracing and related positions by partnering with— 
(A) a State, local, Tribal, or territorial 
health department; or 
(B) one or more nonprofit or community- 
based organizations partnering with such health 
departments; 
(2) how the activities described in paragraph 
(1) will support State efforts to address the demand 
for contact tracing and related positions with respect 
to— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00538
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
539 
(A) the State plans referred to in the head-
ing ‘‘Public Health and Social Services Emer-
gency Fund’’ in title I of division B of the Pay-
check Protection Program and Health Care En-
hancement Act (Public Law 116–139); 
(B) the testing strategy submitted under 
section 30541; and 
(C) the number of eligible individuals that 
the State plans to recruit and train under the 
plans and strategies described in subparagraphs 
(A) and (B); 
(3) the specific strategies for recruiting and 
placement of eligible individuals from or residing 
within the communities in which they will work, in-
cluding— 
(A) plans for the recruitment of eligible in-
dividuals to serve as contact tracers and related 
positions, including dislocated workers, individ-
uals with barriers to employment, veterans, new 
entrants in the workforce, or underemployed or 
furloughed workers, who are from or reside in 
or near the local area in which they will serve, 
and who, to the extent practicable— 
(i) have experience or a background in 
industry-sectors and occupations such as 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00539
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
540 
public health, social services, customer 
service, case management, or occupations 
that require related qualifications, skills, or 
competencies, such as strong interpersonal 
and communication skills, needed for con-
tact tracing or related positions, as de-
scribed in section 30562(d)(2)(E)(ii); or 
(ii) seek to transition to public health 
and public health related occupations upon 
the conclusion of employment in contact 
tracing or related positions; and 
(B) how such strategies will take into ac-
count the diversity of such community, includ-
ing racial, ethnic, socioeconomic, linguistic, or 
geographic diversity; 
(4) the amount, timing, and mechanisms for 
distribution of funds provided to local boards or 
through subgrants as described in subsection (d); 
(5) for eligible entities described in subpara-
graphs (A) through (C) of subsection (a)(4), a de-
scription of how the eligible entity will ensure the eq-
uitable distribution of funds with respect to— 
(A) geography (such as urban and rural 
distribution); 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00540
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
541 
(B) medically underserved populations (as 
defined in section 33(b)(3) of the Public Health 
Service Act (42 U.S.C. 254b(b))); 
(C) health professional shortage areas (as 
defined under section 332(a) of the Public 
Health Service Act (42 U.S.C. 254e(a))); and 
(D) the racial and ethnic diversity of the 
area; and 
(6) for eligible entities who are local boards, a 
description of how a grant to such eligible entity 
would serve the equitable distribution of funds as de-
scribed in paragraph (5). 
(d) SUBGRANT AUTHORIZATION AND APPLICATION 
PROCESS.— 
(1) IN GENERAL.—An eligible entity may award 
a subgrant to one or more community-based organi-
zations for the purposes of partnering with a State 
or local board to conduct outreach and education ac-
tivities to inform potentially eligible individuals 
about employment opportunities in contact tracing 
and related positions. 
(2) APPLICATION.—A community-based organi-
zation shall submit an application at such time and 
in such manner as the eligible entity may reasonably 
require, including— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00541
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
542 
(A) a demonstration of the community- 
based organization’s established expertise and 
effectiveness in community outreach in the local 
area that such organization plans to serve; 
(B) a demonstration of the community- 
based organization’s expertise in providing em-
ployment or public health information to the 
local areas in which such organization plans to 
serve; and 
(C) a description of the expertise of the 
community-based organization in utilizing cul-
turally competent and multilingual strategies in 
the provision of services. 
(e) GRANT DISTRIBUTION.— 
(1) FEDERAL DISTRIBUTION.— 
(A) USE OF FUNDS.— The Secretary of 
Labor shall use the funds appropriated to carry 
out this section as follows: 
(i) Subject to clause (ii), the Secretary 
shall distribute funds among eligible enti-
ties in accordance with a formula to be es-
tablished by the Secretary that provides a 
minimum level of funding to each eligible 
entity that seeks a grant under this section 
and allocates additional funding as follows: 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00542
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
543 
(I) The formula shall give first 
priority based on the number and pro-
portion of contact tracing and related 
positions that the State plans to re-
cruit, place, and train individuals as a 
part of the State strategy described in 
subsection (c)(2)(A). 
(II) Subject to subclause (I), the 
formula shall give priority in accord-
ance with section 30562(c). 
(ii) Not more than 2 percent of the 
funding for administration of the grants 
and for providing technical assistance to 
recipients of funds under this section. 
(B) EQUITABLE DISTRIBUTION.—If the ge-
ographic region served by one or more eligible 
entities overlaps, the Secretary shall distribute 
funds among such entities in such a manner 
that ensures equitable distribution with respect 
to the factors under subsection (c)(5). 
(2) ELIGIBLE ENTITY USE OF FUNDS.—An eli-
gible entity described in subparagraphs (A) through 
(C) of subsection (a)(4)— 
(A) shall, not later than 30 days after the 
date on which the entity receives grant funds 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00543
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
544 
under this section, provide not less than 70 per-
cent of grant funds to local boards for the pur-
pose of carrying out activities in subsection (f); 
(B) may use up to 20 percent of such 
funds to make subgrants to community-based 
organizations in the service area to conduct out-
reach, to potential eligible individuals, as de-
scribed in subsection (d); 
(C) in providing funds to local boards and 
awarding subgrants under this subsection shall 
ensure the equitable distribution with respect to 
the factors described in subsection (c)(5); and 
(D) may use not more than 10 percent of 
the funds awarded under this section for the 
administrative costs of carrying out the grant 
and for providing technical assistance to local 
boards and community-based organizations. 
(3) LOCAL
BOARD
USE
OF
FUNDS.—A local 
board, or an eligible entity that is a local board, 
shall use— 
(A) not less than 60 percent of the funds 
for recruitment and training for COVID–19 
testing, contact tracing, surveillance, contain-
ment, and mitigation established under section 
30561; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00544
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
545 
(B) not less than 30 of the funds to sup-
port the transition of individuals hired as con-
tact tracers and related positions into an edu-
cation or training program, or unsubsidized em-
ployment upon completion of such positions; 
and 
(C) not more than 10 percent of the funds 
for administrative costs. 
(f) ELIGIBLE ACTIVITIES.—The State or local boards 
shall use funds awarded under this section to support the 
recruitment and placement of eligible individuals, training 
and employment transition as related to contact tracing 
and related positions, and for the following activities: 
(1) Establishing or expanding partnerships 
with— 
(A) State, local, Tribal, and territorial 
public health departments; 
(B) community-based health providers, in-
cluding community health centers and rural 
health clinics; 
(C) labor organizations or joint labor man-
agement organizations; 
(D) two-year and four-year institutions of 
higher education (as defined in section 101 of 
the Higher Education Act of 1965 (20 U.S.C. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00545
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
546 
1001)), including institutions eligible to receive 
funds under section 371(a) of the Higher Edu-
cation Act of 1965 (20 U.S.C. 1067q(a)); and 
(E) community action agencies or other 
community-based organizations serving local 
areas in which there is a demand for contact 
tracers and related positions. 
(2) Providing training for contact tracing and 
related positions in coordination with State, local, 
Tribal, or territorial health departments that is con-
sistent with the State or territorial testing and con-
tact tracing strategy and ensuring that eligible indi-
viduals receive compensation while participating in 
such training. 
(3) Providing eligible individuals with— 
(A) adequate and safe equipment, environ-
ments, and facilities for training and super-
vision, as applicable; 
(B) information regarding the wages and 
benefits related to contact tracing and related 
positions, as compared to State, local, and na-
tional averages; 
(C) supplies and equipment needed by the 
program participants to support placement of 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00546
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
547 
an individual in contact tracing and related po-
sitions, as applicable; 
(D) an individualized employment plan for 
each eligible individual, as applicable— 
(i) in coordination with the entity em-
ploying the eligible individual in a contact 
tracing or related position; and 
(ii) which shall include providing a 
case manager to work with each eligible in-
dividual to develop the plan, which may in-
clude— 
(I) identifying employment and 
career goals, and setting appropriate 
achievement objectives to attain such 
goals; and 
(II) exploring career pathways 
that lead to in-demand industries and 
sectors, including in public health and 
related occupations; and 
(E) services for the period during which 
the individual is employed in a contact tracing 
and related position to ensure job retention, 
which may include— 
(i) supportive services throughout the 
term of employment; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00547
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
548 
(ii) a continuation of skills training as 
related to employment as a contact tracer 
or related positions, that is conducted in 
collaboration with the employers of such 
participants; 
(iii) mentorship services and job re-
tention support for eligible individuals; or 
(iv) targeted training for managers 
and workers working with eligible individ-
uals (such as mentors), and human re-
source representatives; 
(4) Supporting the transition and placement in 
unsubsidized employment for eligible individuals 
serving in the contact tracing or related positions 
after such positions are no longer necessary in the 
State or local area, including— 
(A) any additional training and employ-
ment activities as described in section 170(d)(4) 
of the Workforce Innovation and Opportunity 
Act (29 U.S.C. 3225(d)(4)); 
(B) developing the appropriate combina-
tion of services to enable the eligible individual 
to achieve the employment and career goals 
identified under paragraph (3)(D)(ii)(I); and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00548
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
549 
(C) services to assist eligible individuals in 
maintaining employment for not less than 12 
months after the completion of employment in 
contact tracing or related positions, as appro-
priate. 
(5) Any other activities as described in sub-
sections (a)(3) and (b) of section 134 of the Work-
force Innovation and Opportunity Act (29 U.S.C. 
3174). 
(g) 
LIMITATION.—Notwithstanding 
section 
170(d)(3)(A) of the Workforce Innovation and Oppor-
tunity Act (29 U.S.C. 3225(d)(3)(A)), a person may be 
employed in a contact tracing or related position using 
funds under this section for a period not greater than 2 
years. 
(h) REPORTING BY THE DEPARTMENT OF LABOR.— 
(1) IN GENERAL.—Not later than 120 days of 
the enactment of this Act, and once grant funds 
have been expended under this section, the Secretary 
shall report to the Committee on Education and 
Labor of the House of Representatives and the Com-
mittee on Health, Education, Labor and Pensions of 
the Senate, and make publicly available a report 
containing a description of— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00549
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
550 
(A) the number of eligible individuals re-
cruited, hired, and trained as contract tracers 
and related positions; 
(B) the number of individuals successfully 
transitioned to unsubsidized employment or 
training at the completion of employment in 
contact tracing or related positions using funds 
under this subtitle; 
(C) the number of such individuals who 
were unemployed prior to being hired, trained, 
or deployed as described in paragraph (1); 
(D) the performance of each program sup-
ported by funds under this subtitle with respect 
to the indicators of performance under section 
116 of the Workforce Innovation and Oppor-
tunity Act (29 U.S.C. 3141), as applicable; 
(E) the number of individuals in unsub-
sidized employment within six months and 1 
year, respectively, of the conclusion of employ-
ment in contact tracing or related positions 
and, of those, the number of individuals within 
a State, territorial, or local public health de-
partment in an occupation related to public 
health; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00550
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
551 
(F) any information on how eligible enti-
ties, local boards, or community-based organiza-
tions that received funding under this sub-
section were able to support the goals of the na-
tional system for COVID–19 testing, contact 
tracing, surveillance, containment, and mitiga-
tion established under section 30561 of this 
Act; and 
(G) best practices for improving and in-
creasing the transition of individuals employed 
in contract tracing or related positions to per-
manent, full-time employment. 
(2) DISAGGREGATION.—All data reported under 
paragraph (1) shall be disaggregated by race, eth-
nicity, sex, age, and, with respect to individuals with 
barriers to employment, subpopulation of such indi-
viduals, except for when the number of participants 
in a category is insufficient to yield statistically reli-
able information or when the results would reveal 
personally identifiable information about an indi-
vidual participant. 
(i) SPECIAL RULE.—Any funds used for programs 
under this section that are used to fund an apprenticeship 
or apprenticeship program shall only be used for, or pro-
vided to, an apprenticeship or apprenticeship program 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00551
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
552 
that meets the definition of such term subsection (a) of 
this section, including any funds awarded for the purposes 
of grants, contracts, or cooperative agreements, or the de-
velopment, implementation, or administration, of an ap-
prenticeship or an apprenticeship program. 
(j) INFORMATION
SHARING
REQUIREMENT
FOR 
HHS.—The Secretary of Health and Human Services, 
acting through the Director of the Centers for Disease 
Control and Prevention, shall provide the Secretary of 
Labor, acting through the Assistant Secretary of the Em-
ployment and Training Administration, with information 
on grants under section 30562, including— 
(1) the formula used to award such grants to 
State, local, Tribal, and territorial health depart-
ments; 
(2) the dollar amounts of and scope of the work 
funded under such grants; 
(3) the geographic areas served by eligible enti-
ties that receive such grants; and 
(4) the number of contact tracers and related 
positions to be hired using such grants. 
(k) AUTHORIZATION OF APPROPRIATIONS.—Of the 
amounts appropriated to carry out this subtitle, 
$500,000,000 shall be used by the Secretary of Labor to 
carry out subsections (a) through (h) of this section. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00552
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
553 
APPLICATION OF THE SERVICE CONTRACT ACT TO 
CONTRACTS AND GRANTS 
SEC. 30567. 
Contracts and grants which include contact tracing 
as part of the scope of work and that are awarded under 
this subtitle shall require that contract tracers and related 
positions are paid not less than the prevailing wage and 
fringe rates required under chapter 67 of title 41, United 
States Code (commonly known as the ‘‘Service Contract 
Act’’) for the area in which the work is performed. To 
the extent that a nonstandard wage determination is re-
quired to establish a prevailing wage for contact tracers 
and related positions for purposes of this subtitle, the Sec-
retary of Labor shall issue such determination not later 
than 14 days after the date of enactment of this Act, 
based on a job description used by the Centers for Disease 
Control and Prevention and contractors or grantees per-
forming contact tracing for State public health agencies. 
AUTHORIZATION OF APPROPRIATIONS 
SEC. 30568. 
To carry out this subtitle, there are authorized to be 
appropriated $75,000,000,000, to remain available until 
expended. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00553
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
554 
Subtitle E—Demographic Data and Supply Reporting 
Related to COVID–19 
COVID–19 REPORTING PORTAL 
SEC. 30571. 
(a) IN GENERAL.—Not later than 15 days after the 
date of enactment of this Act, the Secretary shall establish 
and maintain an online portal for use by eligible health 
care entities to track and transmit data regarding their 
personal protective equipment and medical supply inven-
tory and capacity related to COVID–19. 
(b) ELIGIBLE HEALTH CARE ENTITIES.—In this sec-
tion, the term ‘‘eligible health care entity’’ means a li-
censed acute care hospital, hospital system, or long-term 
care facility with confirmed cases of COVID–19. 
(c) SUBMISSION.—An eligible health care entity shall 
report using the portal under this section on a biweekly 
basis in order to assist the Secretary in tracking usage 
and need of COVID–related supplies and personnel in a 
regular and real-time manner. 
(d) INCLUDED INFORMATION.—The Secretary shall 
design the portal under this section to include information 
on personal protective equipment and medical supply in-
ventory and capacity related to COVID–19, including with 
respect to the following: 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00554
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
555 
(1) PERSONAL
PROTECTIVE
EQUIPMENT.— 
Total personal protective equipment inventory, in-
cluding, in units, the numbers of N95 masks and 
authorized equivalent respirator masks, surgical 
masks, exam gloves, face shields, isolation gowns, 
and coveralls. 
(2) MEDICAL SUPPLY.— 
(A) Total ventilator inventory, including, in 
units, the number of universal, adult, pediatric, 
and infant ventilators. 
(B) Total diagnostic and serological test 
inventory, including, in units, the number of 
test platforms, tests, test kits, reagents, trans-
port media, swabs, and other materials or sup-
plies determined necessary by the Secretary. 
(3) CAPACITY.— 
(A) Case count measurements, including 
confirmed positive cases and persons under in-
vestigation. 
(B) Total number of staffed beds, includ-
ing medical surgical beds, intensive care beds, 
and critical care beds. 
(C) Available beds, including medical sur-
gical beds, intensive care beds, and critical care 
beds. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00555
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
556 
(D) Total number of COVID–19 patients 
currently utilizing a ventilator. 
(E) Average number of days a COVID–19 
patient is utilizing a ventilator. 
(F) Total number of additionally needed 
professionals in each of the following categories: 
intensivists, critical care physicians, respiratory 
therapists, registered nurses, certified registered 
nurse anesthetists, and laboratory personnel. 
(G) Total number of hospital personnel 
currently not working due to self-isolation fol-
lowing a known or presumed COVID–19 expo-
sure. 
(e) ACCESS TO INFORMATION RELATED TO INVEN-
TORY AND CAPACITY.—The Secretary shall ensure that 
relevant agencies and officials, including the Centers for 
Disease Control and Prevention, the Assistant Secretary 
for Preparedness and Response, and the Federal Emer-
gency Management Agency, have access to information re-
lated to inventory and capacity submitted under this sec-
tion. 
(f) WEEKLY REPORT TO CONGRESS.—On a weekly 
basis, the Secretary shall transmit information related to 
inventory and capacity submitted under this section to the 
appropriate committees of the House and Senate. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00556
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
557 
REGULAR CDC REPORTING ON DEMOGRAPHIC DATA 
SEC. 30572. 
Not later than 14 days after the date of enactment 
of this Act, the Secretary, in coordination with the Direc-
tor of the Centers for Disease Control and Prevention, 
shall amend the reporting under the heading ‘‘Department 
of Health and Human Services—Office of the Secretary— 
Public Health and Social Service Emergency Fund’’ in 
title I of division B of the Paycheck Protection Program 
and Health Care Enhancement Act (Public Law 116–139; 
134 Stat. 620, 626) on the demographic characteristics, 
including race, ethnicity, age, sex, gender, geographic re-
gion, and other relevant factors of individuals tested for 
or diagnosed with COVID–19, to include— 
(1) providing technical assistance to State, 
local, and territorial health departments to improve 
the collection and reporting of such demographic 
data; 
(2) if such data is not so collected or reported, 
the reason why the State, local, or territorial depart-
ment of health has not been able to collect or pro-
vide such information; and 
(3) making a copy of such report available pub-
licly on the website of the Centers for Disease Con-
trol and Prevention. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00557
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
558 
FEDERAL MODERNIZATION FOR HEALTH INEQUITIES 
DATA 
SEC. 30573. 
(a) IN GENERAL.—The Secretary shall work with 
covered agencies to support the modernization of data col-
lection methods and infrastructure at such agencies for 
the purpose of increasing data collection related to health 
inequities, such as racial, ethnic, socioeconomic, sex, gen-
der, and disability disparities. 
(b) COVERED AGENCY DEFINED.—In this section, 
the term ‘‘covered agency’’ means each of the following 
Federal agencies: 
(1) The Agency for Healthcare Research and 
Quality. 
(2) The Centers for Disease Control and Pre-
vention. 
(3) The Centers for Medicare & Medicaid Serv-
ices. 
(4) The Food and Drug Administration. 
(5) The Office of the National Coordinator for 
Health Information Technology. 
(6) The National Institutes of Health. 
(c) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to each covered agency to 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00558
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
559 
carry out this section $4,000,000, to remain available 
until expended. 
MODERNIZATION OF STATE AND LOCAL HEALTH 
INEQUITIES DATA 
SEC. 30574. 
(a) IN GENERAL.—Not later than 6 months after the 
date of enactment of this Act, the Secretary, acting 
through the Director of the Centers for Disease Control 
and Prevention, shall award grants to State, local, and 
territorial health departments in order to support the 
modernization of data collection methods and infrastruc-
ture for the purposes of increasing data related to health 
inequities, such as racial, ethnic, socioeconomic, sex, gen-
der, and disability disparities. The Secretary shall— 
(1) provide guidance, technical assistance, and 
information to grantees under this section on best 
practices regarding culturally competent, accurate, 
and increased data collection and transmission; and 
(2) track performance of grantees under this 
section to help improve their health inequities data 
collection by identifying gaps and taking effective 
steps to support States, localities, and territories in 
addressing the gaps. 
(b) REPORT.—Not later than 1 year after the date 
on which the first grant is awarded under this section, 
the Secretary shall submit to the Committee on Energy 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00559
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
560 
and Commerce of the House of Representatives and the 
Committee on Health, Education, Labor and Pensions of 
the Senate an initial report detailing— 
(1) nationwide best practices for ensuring 
States and localities collect and transmit health in-
equities data; 
(2) nationwide trends which hinder the collec-
tion and transmission of health inequities data; 
(3) Federal best practices for working with 
States and localities to ensure culturally competent, 
accurate, and increased data collection and trans-
mission; and 
(4) any recommended changes to legislative or 
regulatory authority to help improve and increase 
health inequities data collection. 
(c) FINAL REPORT.—Not later than December 31, 
2023, the Secretary shall— 
(1) update and finalize the initial report under 
subsection (b); and 
(2) submit such final report to the committees 
specified in such subsection. 
(d) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$100,000,000, to remain available until expended. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00560
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
561 
TRIBAL FUNDING TO RESEARCH HEALTH INEQUITIES 
INCLUDING COVID–19 
SEC. 30575. 
(a) IN GENERAL.—Not later than 6 months after the 
date of enactment of this Act, the Director of the Indian 
Health Service, in coordination with Tribal Epidemiology 
Centers and other Federal agencies, as appropriate, shall 
conduct or support research and field studies for the pur-
poses of improved understanding of Tribal health inequi-
ties among American Indians and Alaska Natives, includ-
ing with respect to— 
(1) disparities related to COVID–19; 
(2) public health surveillance and infrastructure 
regarding unmet needs in Indian country and Urban 
Indian communities; 
(3) population-based health disparities; 
(4) barriers to health care services; 
(5) the impact of socioeconomic status; and 
(6) factors contributing to Tribal health inequi-
ties. 
(b) CONSULTATION, CONFER, AND COORDINATION.— 
In carrying out this section, the Director of the Indian 
Health Service shall— 
(1) consult with Indian Tribes and Tribal orga-
nizations; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00561
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
562 
(2) confer with Urban Indian organizations; 
and 
(3) coordinate with the Director of the Centers 
for Disease Control and Prevention and the Director 
of the National Institutes of Health. 
(c) PROCESS.—Not later than 60 days after the date 
of enactment of this Act, the Director of the Indian Health 
Service shall establish a nationally representative panel to 
establish processes and procedures for the research and 
field studies conducted or supported under subsection (a). 
The Director shall ensure that, at a minimum, the panel 
consists of the following individuals: 
(1) Elected Tribal leaders or their designees. 
(2) Tribal public health practitioners and ex-
perts from the national and regional levels. 
(d) DUTIES.—The panel established under subsection 
(c) shall, at a minimum— 
(1) advise the Director of the Indian Health 
Service on the processes and procedures regarding 
the design, implementation, and evaluation of, and 
reporting on, research and field studies conducted or 
supported under this section; 
(2) develop and share resources on Tribal pub-
lic health data surveillance and reporting, including 
best practices; and 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00562
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
563 
(3) carry out such other activities as may be 
appropriate to establish processes and procedures for 
the research and field studies conducted or sup-
ported under subsection (a). 
(e) REPORT.—Not later than 1 year after expending 
all funds made available to carry out this section, the Di-
rector of the Indian Health Service, in coordination with 
the panel established under subsection (c), shall submit 
an initial report on the results of the research and field 
studies under this section to— 
(1) the Committee on Energy and Commerce 
and the Committee on Natural Resources of the 
House of Representatives; and 
(2) the Committee on Indian Affairs and the 
Committee on Health, Education, Labor and Pen-
sions of the Senate. 
(f) TRIBAL DATA SOVEREIGNTY.—The Director of 
the Indian Health Service shall ensure that all research 
and field studies conducted or supported under this sec-
tion are tribally-directed and carried out in a manner 
which ensures Tribal-direction of all data collected under 
this section— 
(1) according to Tribal best practices regarding 
research design and implementation, including by 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00563
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
564 
ensuring the consent of the Tribes involved to public 
reporting of Tribal data; 
(2) according to all relevant and applicable 
Tribal, professional, institutional, and Federal 
standards for conducting research and governing re-
search ethics; 
(3) with the prior and informed consent of any 
Indian Tribe participating in the research or sharing 
data for use under this section; and 
(4) in a manner that respects the inherent sov-
ereignty of Indian Tribes, including Tribal govern-
ance of data and research. 
(g) FINAL REPORT.—Not later than December 31, 
2023, the Director of the Indian Health Service shall— 
(1) update and finalize the initial report under 
subsection (e); and 
(2) submit such final report to the committees 
specified in such subsection. 
(h) DEFINITIONS.—In this section: 
(1) The terms ‘‘Indian Tribe’’ and ‘‘Tribal or-
ganization’’ have the meanings given to such terms 
in section 4 of the Indian Self-Determination and 
Education Assistance Act (25 U.S.C. 5304). 
(2) The term ‘‘Urban Indian organization’’ has 
the meaning given to such term in section 4 of the 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00564
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
565 
Indian Health Care Improvement Act (25 U.S.C. 
1603). 
(i) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$25,000,000, to remain available until expended. 
CDC FIELD STUDIES PERTAINING TO SPECIFIC HEALTH 
INEQUITIES 
SEC. 30576. 
(a) IN GENERAL.—Not later than 90 days after the 
date of enactment of this Act, the Secretary, acting 
through the Centers for Disease Control and Prevention, 
in collaboration with State, local, and territorial health de-
partments, shall complete (by the reporting deadline in 
subsection (b)) field studies to better understand health 
inequities that are not currently tracked by the Secretary. 
Such studies shall include an analysis of— 
(1) the impact of socioeconomic status on 
health care access and disease outcomes, including 
COVID–19 outcomes; 
(2) the impact of disability status on health 
care access and disease outcomes, including COVID– 
19 outcomes; 
(3) the impact of language preference on health 
care access and disease outcomes, including COVID– 
19 outcomes; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00565
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
566 
(4) factors contributing to disparities in health 
outcomes for the COVID–19 pandemic; and 
(5) other topics related to disparities in health 
outcomes for the COVID–19 pandemic, as deter-
mined by the Secretary. 
(b) REPORT.—Not later than December 31, 2021, 
the Secretary shall submit to the Committee on Energy 
and Commerce of the House of Representatives and the 
Committee on Health, Education, Labor and Pensions of 
the Senate an initial report on the results of the field stud-
ies under this section. 
(c) FINAL REPORT.—Not later than December 31, 
2023, the Secretary shall— 
(1) update and finalize the initial report under 
subsection (b); and 
(2) submit such final report to the committees 
specified in such subsection. 
(d) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$25,000,000, to remain available until expended. 
ADDITIONAL
REPORTING
TO
CONGRESS
ON
THE
RACE 
AND ETHNICITY RATES OF COVID–19 TESTING, HOS-
PITALIZATIONS, AND MORTALITIES 
SEC. 30577. 
(a) IN GENERAL.—Not later than August 1, 2020, 
the Secretary shall submit to the Committee on Appro-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00566
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
567 
priations and the Committee on Energy and Commerce 
of the House of Representatives and the Committee on 
Appropriations and the Committee on Health, Education, 
Labor and Pensions of the Senate an initial report— 
(1) describing the testing, positive diagnoses, 
hospitalization, intensive care admissions, and mor-
tality 
rates 
associated 
with 
COVID–19, 
disaggregated by race, ethnicity, age, sex, gender, 
geographic region, and other relevant factors as de-
termined by the Secretary; 
(2) including an analysis of any variances of 
testing, positive diagnoses, hospitalizations, and 
deaths by demographic characteristics; and 
(3) including proposals for evidenced-based re-
sponse strategies to reduce disparities related to 
COVID–19. 
(b) FINAL REPORT.—Not later than December 31, 
2024, the Secretary shall— 
(1) update and finalize the initial report under 
subsection (a); and 
(2) submit such final report to the committees 
specified in such subsection. 
(c) COORDINATION.—In preparing the report sub-
mitted under this section, the Secretary shall take into ac-
count and otherwise coordinate such report with reporting 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00567
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
568 
required under section 30572 and under the heading ‘‘De-
partment of Health and Human Services—Office of the 
Secretary—Public Health and Social Service Emergency 
Fund’’ in title I of division B of the Paycheck Protection 
Program and Health Care Enhancement Act (Public Law 
116–139; 134 Stat. 620, 626). 
Subtitle F—Miscellaneous 
TECHNICAL CORRECTIONS TO AMENDMENTS MADE BY 
CARES ACT 
SEC. 30581. 
(a) The amendments made by this section shall take 
effect as if included in the enactment of the CARES Act 
(Public Law 116–136). 
(b) Section 3112 of division A of the CARES Act 
(Public Law 116–136) is amended— 
(1) in subsection (a)(2)(A), by striking the 
comma before ‘‘or a permanent’’; 
(2) in subsection (d)(1), by striking ‘‘and sub-
paragraphs (A) and (B)’’ and inserting ‘‘as subpara-
graphs (A) and (B)’’; and 
(3) in subsection (e), by striking ‘‘Drug, Cos-
metic Act’’ and inserting ‘‘Drug, and Cosmetic Act’’. 
(c) Section 6001(a)(1)(D) of division F of the Fami-
lies First Coronavirus Response Act (Public Law 116– 
127), as amended by section 3201 of division A of the 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00568
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
569 
CARES Act (Public Law 116–136), is amended by strik-
ing ‘‘other test that’’. 
(d) Subsection (k)(9) of section 543 of the Public 
Health Service Act (42 U.S.C. 290dd–2), as added by sec-
tion 3221(d) of division A of the CARES Act (Public Law 
116–136), is amended by striking ‘‘unprotected health in-
formation’’ and inserting ‘‘unsecured protected health in-
formation’’. 
(e) Section 3401(2)(D) of division A of the CARES 
Act (Public Law 116–136), is amended by striking ‘‘Not 
Later than’’ and inserting ‘‘Not later than’’. 
(f) Section 831(f) of the Public Health Service Act, 
as redesignated by section 3404(a)(6)(E) and amended by 
section 3404(a)(6)(G) of division A of the CARES Act 
(Public Law 116–136), is amended by striking ‘‘a health 
care facility, or a partnership of such a school and facil-
ity’’. 
(g) Section 846(i) of the Public Health Service Act, 
as amended by section 3404(i)(8)(C) of division A of the 
CARES Act (Public Law 116–136), is amended by strik-
ing ‘‘871(b),,’’ and inserting ‘‘871(b),’’. 
(h) Section 3606(a)(1)(A) of division A of the 
CARES Act (Public Law 116–136) is amended by striking 
‘‘In general’’ and inserting ‘‘IN GENERAL’’. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00569
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
570 
(i) Section 3856(b)(1) of division A of the CARES 
Act (Public Law 116–136) is amended to read as follows: 
‘‘(1) IN GENERAL.—Section 905(b)(4) of the 
FDA Reauthorization Act of 2017 (Public Law 115– 
52) is amended by striking ‘Section 744H(e)(2)(B) 
of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 379j–52(e)(2)(B))’ and inserting ‘Section 
744H(f)(2)(B) of the Federal Food, Drug, and Cos-
metic Act, as redesignated by section 403(c)(1) of 
this Act,’.’’. 
TITLE VI—PUBLIC HEALTH ASSISTANCE 
Subtitle A—Assistance to Providers and Health System 
HEALTH CARE PROVIDER RELIEF FUND 
SEC. 30611. 
(a) IN GENERAL.—Not later than 7 days after the 
date of enactment of this Act, the Secretary, acting 
through the Administrator of the Health Resources and 
Services Administration, shall establish a program under 
which the Secretary shall reimburse, through grants or 
other mechanisms, eligible health care providers for eligi-
ble expenses or lost revenues occurring during calendar 
quarters beginning on or after January 1, 2020, to pre-
vent, prepare for, and respond to COVID–19, in an 
amount calculated under subsection (c). 
(b) QUARTERLY BASIS.— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00570
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
571 
(1) SUBMISSION OF APPLICATIONS.—The Sec-
retary shall give applicants a period of 7 calendar 
days after the close of a quarter to submit applica-
tions under this section with respect to such quarter, 
except that the Secretary shall give applicants a pe-
riod of 7 calendar days after the date of enactment 
of this Act to submit applications with respect to the 
quarter beginning on January 1, 2020, if the appli-
cant has not previously submitted an application 
with the respect to such quarter. 
(2) REVIEW
AND
PAYMENT.—The Secretary 
shall— 
(A) review applications and make awards 
of reimbursement under this section on a quar-
terly basis; and 
(B) award the reimbursements under this 
section for a quarter not later than 14 calendar 
days after the close of the quarter, except that 
the Secretary shall award the reimbursements 
under this section for the quarter beginning on 
January 1, 2020, not later than 14 calendar 
days after the date of enactment of this Act. 
(c) CALCULATION.— 
(1) IN
GENERAL.—The amount of the reim-
bursement to an eligible health provider under this 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00571
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
572 
section with respect to a calendar quarter shall 
equal— 
(A) the sum of— 
(i) 100 percent of the eligible ex-
penses, as described in subsection (d), of 
the provider during the quarter; and 
(ii) subject to paragraph (3), 60 per-
cent of the lost revenues, as described in 
subsection (e), of the provider during the 
quarter; less 
(B) any funds that are— 
(i) received by the provider during the 
quarter pursuant to the Coronavirus Pre-
paredness and Response Supplemental Ap-
propriations Act, 2020 (Public Law 116– 
123), the Families First Coronavirus Re-
sponse Act (Public Law 116–127), the 
CARES Act (Public Law 116–136), or the 
Paycheck Protection Program and Health 
Care Enhancement Act (Public Law 116– 
139); and 
(ii) not required to be repaid. 
(2) CARRYOVER.—If the amount determined 
under paragraph (1)(B) for a calendar quarter with 
respect to an eligible health care provider exceeds 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00572
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
573 
the amount determined under subparagraph (A) 
with respect to such provider and quarter, the 
amount of such difference shall be applied in making 
the calculation under this subsection, over each sub-
sequent calendar quarter for which the eligible 
health care provider seeks reimbursement under this 
section. 
(3) 
LOST
REVENUE
LIMITATION.—If 
the 
amount determined under subsection (e) with re-
spect to the lost revenue of an eligible health care 
provider for a calendar quarter does not exceed an 
amount that equals 10 percent of the net patient 
revenue (as defined in such subsection) of the pro-
vider for the corresponding quarter in 2019, the ad-
dend under paragraph (1)(A)(ii), in making the cal-
culation under paragraph (1), is deemed to be zero. 
(d) ELIGIBLE EXPENSES.—Subject to subsection 
(h)(1), expenses eligible for reimbursement under this sec-
tion include expenses for— 
(1) building or construction of temporary struc-
tures; 
(2) leasing of properties; 
(3) medical supplies and equipment including 
personal protective equipment; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00573
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
574 
(4) in vitro diagnostic tests, serological tests, or 
testing supplies; 
(5) increased workforce and trainings; 
(6) emergency operation centers; 
(7) construction or retrofitting of facilities; 
(8) mobile testing units; 
(9) surge capacity; 
(10) retention of workforce; and 
(11) such other items and services as the Sec-
retary determines to be appropriate, in consultation 
with relevant stakeholders. 
(e) LOST REVENUES.— 
(1) IN GENERAL.—Subject to subsection (h)(1), 
for purposes of subsection (c)(1)(A)(ii), the lost rev-
enues of an eligible health care provider, with re-
spect to the calendar quarter involved, shall be equal 
to— 
(A) net patient revenue of the provider for 
the corresponding quarter in 2019 minus net 
patient revenue of the provider for such quar-
ter; less 
(B) the savings of the provider during the 
calendar quarter involved attributable to fore-
gone wages, payroll taxes, and benefits of per-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00574
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
575 
sonnel who were furloughed or laid off by the 
provider during that quarter. 
(2) NET
PATIENT
REVENUE
DEFINED.—For 
purposes of paragraph (1)(A), the term ‘‘net patient 
revenue’’, with respect to an eligible health care pro-
vider and a calendar quarter, means the sum of— 
(A) 200 percent of the total amount of re-
imbursement received by the provider during 
the quarter for all items and services furnished 
under a State plan or a waiver of a State plan 
under title XIX of the Social Security Act (42 
U.S.C. 1396 et seq.); 
(B) 125 percent of the total amount of re-
imbursement received by the provider during 
the quarter for all items and services furnished 
under title XVIII of the Social Security Act (42 
U.S.C. 1395 et seq.); and 
(C) 100 percent of the total amount of re-
imbursement not described in subparagraph (A) 
or (B) received by the provider during the quar-
ter for all items and services. 
(f) INSUFFICIENT FUNDS FOR A QUARTER.—If there 
are insufficient funds made available to reimburse all eligi-
ble health care providers for all eligible expenses and lost 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00575
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
576 
revenues for a quarter in accordance with this section, the 
Secretary shall— 
(1) prioritize reimbursement of eligible ex-
penses; and 
(2) using the entirety of the remaining funds, 
uniformly reduce the percentage of lost revenues 
otherwise applicable under subsection (c)(1)(A)(ii) to 
the extent necessary to reimburse a portion of the 
lost revenues of all eligible health care providers ap-
plying for reimbursement. 
(g) APPLICATION.—A health care provider seeking 
reimbursement under this section for a calendar quarter 
shall submit to the Secretary an application that— 
(1) provides documentation demonstrating that 
the health care provider is an eligible health care 
provider; 
(2) includes a valid tax identification number of 
the health care provider; 
(3) attests to the eligible expenses and lost rev-
enues of the health care provider, as described in 
subsection (d), occurring during the calendar quar-
ter; 
(4) includes an itemized listing of each such eli-
gible expense, including expenses incurred in pro-
viding uncompensated care; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00576
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
577 
(5) for purposes of subsection (c)(3), attests to 
whether the amount determined under subsection (e) 
with respect to the lost revenue of an eligible health 
care provider for a calendar quarter exceeds an 
amount that equals 10 percent of the net patient 
revenue (as defined in such subsection) of the pro-
vider for the corresponding quarter in 2019; 
(6) includes projections of the eligible expenses 
and lost revenues of the health care provider, as de-
scribed in subsection (c), for the calendar quarter 
that immediately follows the calendar for which re-
imbursement is sought; and 
(7) indicates the dollar amounts described in 
each of subparagraphs (A) and (B) of subsection 
(e)(1) and subparagraphs (A), (B), and (C) of sub-
section (e)(2) for the calendar quarter. 
(h) LIMITATIONS.— 
(1) NO
DUPLICATIVE
REIMBURSEMENT.—The 
Secretary may not provide, and a health care pro-
vider may not accept, reimbursement under this sec-
tion for expenses or losses with respect to which— 
(A) the eligible health care provider is re-
imbursed from other sources; or 
(B) other sources are obligated to reim-
burse the provider. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00577
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
578 
(2) NO
EXECUTIVE
COMPENSATION.—Reim-
bursement for eligible expenses (as described in sub-
section (e)) and lost revenues (as described in sub-
section (f)) shall not include compensation or bene-
fits, including salary, bonuses, awards of stock, or 
other financial benefits, for an officer or employee 
described in section 4004(a)(2) of the CARES Act 
(Public Law 116–136). 
(i) NO BALANCE BILLING AS CONDITION OF RE-
CEIPT OF FUNDS.— 
(1) PROTECTING
INDIVIDUALS
ENROLLED
IN 
HEALTH PLANS.—As a condition of receipt of reim-
bursement under this section, a health care provider, 
in the case such provider furnishes during the emer-
gency period described in section 1135(g)(1)(B) of 
the Social Security Act (42 U.S.C. 1320b– 
5(g)(1)(B)) (whether before, on, or after, the date 
on which the provider submits an application under 
this section) a medically necessary item or service 
described in subparagraph (A), (B), or (C) of para-
graph (3) to an individual who is described in such 
subparagraph (A), (B), or (C), respectively, and en-
rolled in a group health plan or group or individual 
health insurance coverage offered by a health insur-
ance issuer (including grandfathered health plans as 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00578
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
579 
defined in section 1251(e) of the Patient Protection 
and Affordable Care Act (42 U.S.C. 18011(e)) and 
such provider is a nonparticipating provider with re-
spect to such plan or coverage and such plan or cov-
erage and such items and services would otherwise 
be covered under such plan if furnished by a partici-
pating provider— 
(A) may not bill or otherwise hold liable 
such individual for a payment amount for such 
item or service that is more than the cost-shar-
ing amount that would apply under such plan 
or coverage for such item or service if such pro-
vider furnishing such service were a partici-
pating provider with respect to such plan or 
coverage; 
(B) shall reimburse such individual in a 
timely manner for any amount for such item or 
service paid by the individual to such provider 
in excess of such cost-sharing amount; 
(C) shall submit any claim for such item or 
service directly to the plan or coverage; and 
(D) shall not bill the individual for such 
cost-sharing amount until such individual is in-
formed by the plan or coverage of the required 
payment amount. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00579
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
580 
(2) PROTECTING
UNINSURED
INDIVIDUALS.— 
As a condition of receipt of reimbursement under 
this section, a health care provider, in the case such 
reimbursement is with respect to expenses incurred 
in providing uncompensated care (as described in 
subsection (g)(4)) with respect to a medically nec-
essary item or service described in subparagraph 
(A), (B), or (C) of paragraph (3) furnished during 
such emergency period (whether before, on, or after, 
the date on which the provider submits an applica-
tion under this section) by the provider to an indi-
vidual who is described in such subparagraph (A), 
(B), or (C), respectively— 
(A) shall consider such reimbursement as 
payment in full with respect to such item or 
service so furnished to such individual; 
(B) may not bill or otherwise hold liable 
such individual for any payment for such item 
or service so furnished to such individual; and 
(C) shall reimburse such individual in a 
timely manner for any amount for such item or 
service paid by the individual to such provider. 
(3) MEDICALLY NECESSARY ITEMS AND SERV-
ICES DESCRIBED.—For purposes of this subsection, 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00580
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
581 
medically necessary items and services described in 
this paragraph are— 
(A) medically necessary items and services 
(including in-person or telehealth visits in which 
such items and services are furnished) that are 
furnished to an individual who has been diag-
nosed with (or after provision of the items and 
services is diagnosed with) COVID–19 to treat 
or mitigate the effects of COVID–19; 
(B) medically necessary items and services 
(including in-person or telehealth visits in which 
such items and services are furnished) that are 
furnished to an individual who is presumed, in 
accordance 
with 
paragraph 
(4), 
to 
have 
COVID–19 but is never diagnosed as such; and 
(C) a diagnostic test (and administration 
of such test) as described in section 6001(a) of 
division F of the Families First Coronavirus 
Response Act (42 U.S.C. 1320b–5 note) admin-
istered to an individual. 
(4) PRESUMPTIVE
CASE
OF
COVID–19.—For 
purposes of paragraph (3)(B), an individual shall be 
presumed to have COVID–19 if the medical record 
documentation of the individual supports a diagnosis 
of COVID–19, even if the individual does not have 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00581
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
582 
a positive in vitro diagnostic test result in the med-
ical record of the individual. 
(5) PENALTY.—In the case of an eligible health 
care provider that is paid a reimbursement under 
this section and that is in violation of paragraph (1) 
or (2), in addition to any other penalties that may 
be prescribed by law, the Secretary may recoup from 
such provider up to the full amount of reimburse-
ment the provider receives under this section. 
(6) DEFINITIONS.—In this subsection: 
(A) NONPARTICIPATING
PROVIDER.—The 
term ‘‘nonparticipating provider’’ means, with 
respect to an item or service and group health 
plan or group or individual health insurance 
coverage offered by a health insurance issuer, a 
health care provider that does not have a con-
tractual relationship directly or indirectly with 
the plan or issuer, respectively, for furnishing 
such an item or service under the plan or cov-
erage. 
(B) PARTICIPATING PROVIDER.—The term 
‘‘participating provider’’ means, with respect to 
an item or service and group health plan or 
group or individual health insurance coverage 
offered by a health insurance issuer, a health 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00582
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
583 
care provider that has a contractual relation-
ship directly or indirectly with the plan or 
issuer, respectively, for furnishing such an item 
or service under the plan or coverage. 
(C) GROUP HEALTH PLAN, HEALTH INSUR-
ANCE
COVERAGE.—The terms ‘‘group health 
plan’’, ‘‘health insurance issuer’’, ‘‘group health 
insurance coverage’’, and ‘‘individual health in-
surance coverage’’ shall have the meanings 
given such terms under section 2791 of the 
Public Health Service Act (42 U.S.C. 300gg– 
91). 
(j) REPORTS.— 
(1) AWARD INFORMATION.—In making awards 
under this section, the Secretary shall post in a 
searchable, electronic format, a list of all recipients 
and awards pursuant to funding authorized under 
this section. 
(2) REPORTS BY RECIPIENTS.—Each recipient 
of an award under this section shall, as a condition 
on receipt of such award, submit reports and main-
tain documentation, in such form, at such time, and 
containing such information, as the Secretary deter-
mines is needed to ensure compliance with this sec-
tion. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00583
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
629 
of the application that the application is incomplete or the 
plan is not eligible under this section. Such notice shall 
specify the reasons the plan is ineligible for a special parti-
tion or information needed to complete the application. If 
a plan is denied partition under this subsection, the plan 
may submit a revised application under this section. Any 
revised application for special partition submitted by a 
plan shall be deemed approved unless the corporation noti-
fies the plan within 120 days of the filing of the revised 
application that the application is incomplete or the plan 
is not eligible under this section. A special partition order 
issued by the corporation shall be effective no later than 
120 days after a plan’s special partition application is ap-
proved by the corporation or deemed approved. 
‘‘(e) AMOUNT AND MANNER OF SPECIAL PARTITION 
ASSISTANCE.— 
‘‘(1) IN GENERAL.—The liabilities of an eligible 
multiemployer plan that the corporation assumes 
pursuant to a special partition order under this sec-
tion shall be the amount necessary for the plan to 
meet its funding goals described in subsection (g). 
‘‘(2) NO CAP.—Liabilities assumed by the cor-
poration pursuant to a special partition order under 
this section shall not be capped by the guarantee 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 00629
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS